Scroll Top

Cervicheck

Pragmatech aims to address these unique problems through a patent-pending point-of-care screening test that detects cervical lesions, using samples which have been self-collected comfortably and accurately by a patented self-sampling kit.

Comfort

The CERVICHECK™ Self-sampling Kit empowers women to self-collect their cervical samples privately, comfortably, and accurately. The self-collected samples can not only be used for screening with the CERVICHECK™ Screening Kit, but also for HPV and follow-up triage tests.

Convenience

The CERVICHECK™ Screening Kit enables Point-of-care detection of cervical lesions. Thus, this test can be taken up easily at a pathology lab, a doctor’s clinic or at a health screening camp – and more importantly results are available almost immediately.

Care

The CERVICHECK™ Screening Kit enables immediate detection of early-stage cervical lesions, at a point when treatment can be imparted without any delay, thus supporting WHO’s screen-and-treat policy.

The CERVICHECK™ Kit Sampling + Screening

A point-of-care primary screening test that detects cervical lesions at a treatable point (≥ CIN1), with samples collected using a patented self- sampling device.

The CERVICHECK™ Collection Device

Unlike other self-sampling kits a v a i l a b l e g l o b a l l y , o u r innovative design enables collection of cells from the “transformation zone/Surface of the Cervix” which in-turn allows the triaging.

The CERVICHECK™ Workflow
Sampling + Screening

A point-of-care primary screening test that detects cervical lesions at a treatable point (≥ CIN1), with samples collected using a patented self- sampling device.
Strategic Approach
Private Sector Strategy: Target
private healthcare practitioners through outreach programs, corporate tie-ups for wellness programs, and establish a robust online presence for greater brand visibility and product accessibility .
Public Health Sector Penetration
Utilize awareness campaigns, pilot programs, and public procurement to integrate Healtheasi's screening devices within public health centers, demonstrating cost-effectiveness, accuracy, and compliance .
Partnerships in Government Sector
Collaborate with health departments at various levels to ensure widespread adoption of Healtheasi's screening devices, participating in health initiatives to enhance public health outreach .

The Market Opportunity Cervical Cancer Preventive Screening

Indian Market Opportunity
Global for PAP and HPV: USD 2.5B (INR 19K Crore), growing 33.5% annually³
1.Total Available Market (TAM)
2.Serviceable Available Market (SAM)
3.Serviceable Obtainable Market (SOM)

Democratizing Cervical Cancer Screening industry in India and LMI Countries

SUBSCRIBE AND KEEP IN TOUCH WITH OUR NEWS!

News Letter

Subscribe Now
location_1-line-46
Office Address

Quadrant-1, S3, Cyber Towers,
Hi-Tech City, Survey No. 64, Madhapur
Hyderabad, Telangana-500081

time_line-8
Working Hours

MONDAY-FRIDAY: 9:00 – 18:00
SATURDAY: 11:00 – 17:00
SUNDAY: CLOSED

Communication_1-line-37
Hotline
MONDAY-PHONE: +1 916-875-2235
MOBILE: +1 916-875-2235
FAX: +1 916-875-2235